patients with ph +ve and/or bcr/abl +ve all
Item
patients with ph +ve and/or bcr/abl +ve all, either in 1st chr (independently from the molecular status) for study a, or at diagnosis and untreated for study b;
boolean
C0079011 (UMLS CUI [1])
C1960397 (UMLS CUI [2])
Age
Item
age >18 years and <60 for study a, >60 for study b;
boolean
C0001779 (UMLS CUI [1])
informed consent
Item
written voluntary informed consent.
boolean
C0021430 (UMLS CUI [1])
patients of childbearing potential without a negative pregnancy test
Item
patients of childbearing potential without a negative pregnancy test prior to the initiation of study. barrier contraceptive precautions are to be used throughout the trial in both sexes;
boolean
C1960468 (UMLS CUI [1])
C0549206 (UMLS CUI [2])
steroid therapy
Item
pretreatment with steroids for more than 10 days in study b;
boolean
C0149783 (UMLS CUI [1])
serum bilirubin and creatinine
Item
serum bilirubin and creatinine values >3 the upper limit of normal range;
boolean
C1278039 (UMLS CUI [1])
C0201976 (UMLS CUI [2])
liver enzymes
Item
sgot and sgpt values >3 the upper limit of the normal range;
boolean
C1860080 (UMLS CUI [1])
study subject participation status
Item
patients who had received any other investigational agent within 4 weeks before the enrollment;
boolean
C2348568 (UMLS CUI [1])
cardiovascular diseases
Item
patients with cardiovascular diseases grade >3 according to the new york heart association (see appendix 1);
boolean
C0007222 (UMLS CUI [1])
compliance behavior
Item
patients with a history of non compliance to medical regimen or who are considered potentially unreliable;
boolean
C1321605 (UMLS CUI [1])
psychiatric disorders
Item
patients with moderate/severe mood or psychiatric disorders;
boolean
C0004936 (UMLS CUI [1])
malignancy
Item
concomitant neoplasia.
boolean
C0006826 (UMLS CUI [1])